PARPARADIGM BIOPHARMACEUTICALS LIMITED..Market sensitive

Paradigm Achieves 50% Patient Dosing in Phase 3

Date and time
Announcement type
Company Update
Show details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASXOpen original PDFPAR announcement history

Recent PAR announcements